Levels of vascular endothelial growth factor (VEGF), epidermal growth factor (EGF) and carcinoembryonic antigen (CEA), for example, have been described to be significantly elevated in breast cancer patients10. This evidence concerns the gene CEACAM5 and breast cancer.